GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » BNC Korea Co Ltd (XKRX:256840) » Definitions » Deferred Policy Acquisition Costs

BNC Korea Co (XKRX:256840) Deferred Policy Acquisition Costs


View and export this data going back to 2016. Start your Free Trial

What is BNC Korea Co Deferred Policy Acquisition Costs?

Deferred Policy Acquisition Costs only applies to banks and insurance companies.


BNC Korea Co Business Description

Industry
Traded in Other Exchanges
N/A
Address
62 Seongseogongdan-ro 11-gil, Dalseo-gu, No 405, Structure 1, Daegu Techno Park Venture Factory, Daegu, KOR, 42713
BNC Korea Co Ltd is a Korean healthcare company. The company is engaged in manufacturing medicinal chemicals, antibiotics, and biological products. IIts product offering includes cutegel, cutegel lidocaine, FLORE lidocaine, ChungA-an, cutegel-M under the HA filler product line. While it also offers Skin booster filler, hibarry, gentaQ, and I.st products.